Galapagos (GLPG)
(Delayed Data from NSDQ)
$32.56 USD
-0.32 (-0.97%)
Updated Aug 8, 2025 04:00 PM ET
After-Market: $32.56 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth D Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
GLPG 32.56 -0.32(-0.97%)
Will GLPG be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for GLPG based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for GLPG
Galapagos (GLPG) Loses -21.19% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Biotech Stock Roundup: REGN's Drug Approval, LXRX, RYTM Stocks Gain on Update & More
GLPG: What are Zacks experts saying now?
Zacks Private Portfolio Services
Galapagos (GLPG) Up on FDA Nod to Begin Phase I/II Lymphoma Study
Other News for GLPG
Galapagos (GLPG) Secures RMAT Status for Innovative Cancer Therapy
Galapagos granted RMAT designation to GLPG5101 by FDA
Galapagos (GLPG) Downgraded by Deutsche Bank with New Price Target
Galapagos (GLPG) Downgraded to Sell Amid Uncertainty
Deutsche Bank downgrades Galapagos to Sell amid 'too much uncertainty'